Nu Skin Enterprises (NUS) Earns Buy Rating from Pivotal Research

Share on StockTwits

Nu Skin Enterprises (NYSE:NUS)‘s stock had its “buy” rating restated by analysts at Pivotal Research in a research note issued on Wednesday. They presently have a $85.00 target price on the stock. Pivotal Research’s price objective would indicate a potential upside of 43.44% from the company’s current price.

A number of other analysts have also commented on the company. Zacks Investment Research lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Tuesday, January 8th. TheStreet lowered Nu Skin Enterprises from a “b” rating to a “c+” rating in a research note on Thursday, February 14th. ValuEngine lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Friday, February 8th. Bank of America set a $65.00 price objective on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Friday, March 1st. Finally, Citigroup set a $86.00 price objective on Nu Skin Enterprises and gave the company a “buy” rating in a research note on Friday, February 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $80.25.

Nu Skin Enterprises stock opened at $59.26 on Wednesday. The company has a current ratio of 1.82, a quick ratio of 1.15 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $3.25 billion, a price-to-earnings ratio of 16.84, a PEG ratio of 1.50 and a beta of 0.69. Nu Skin Enterprises has a fifty-two week low of $56.09 and a fifty-two week high of $88.68.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Wednesday, February 13th. The company reported $1.05 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.05. The company had revenue of $683.29 million for the quarter, compared to analyst estimates of $676.76 million. Nu Skin Enterprises had a return on equity of 25.98% and a net margin of 4.55%. Nu Skin Enterprises’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.20 earnings per share. Equities analysts predict that Nu Skin Enterprises will post 3.91 EPS for the current year.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 1,250 shares of the firm’s stock in a transaction dated Wednesday, January 2nd. The stock was sold at an average price of $60.60, for a total value of $75,750.00. Following the sale, the general counsel now directly owns 32,621 shares of the company’s stock, valued at approximately $1,976,832.60. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 3.00% of the stock is currently owned by company insiders.

Large investors have recently modified their holdings of the business. Retirement Systems of Alabama raised its holdings in shares of Nu Skin Enterprises by 0.4% during the 4th quarter. Retirement Systems of Alabama now owns 72,023 shares of the company’s stock valued at $4,417,000 after buying an additional 260 shares during the period. Commerzbank Aktiengesellschaft FI raised its holdings in shares of Nu Skin Enterprises by 0.5% during the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 55,576 shares of the company’s stock valued at $3,408,000 after buying an additional 276 shares during the period. United Services Automobile Association raised its holdings in shares of Nu Skin Enterprises by 2.0% during the 4th quarter. United Services Automobile Association now owns 14,448 shares of the company’s stock valued at $886,000 after buying an additional 277 shares during the period. American International Group Inc. raised its holdings in shares of Nu Skin Enterprises by 0.3% during the 4th quarter. American International Group Inc. now owns 113,316 shares of the company’s stock valued at $6,950,000 after buying an additional 344 shares during the period. Finally, Advisors Asset Management Inc. raised its holdings in shares of Nu Skin Enterprises by 16.0% during the 4th quarter. Advisors Asset Management Inc. now owns 2,720 shares of the company’s stock valued at $167,000 after buying an additional 375 shares during the period. 74.27% of the stock is currently owned by hedge funds and other institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Featured Article: What is a stock buyback?

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply